Abits
ABTS
FRMO CORP
FRMO
Mawson Infrastructure
MIGI
Ebang International
EBON
BIT Mining
BTCM
US Stock MarketDetailed Quotes
BLU BELLUS Health
- 14.740
- 0.0000.00%
Close Jun 29 09:30 ET
1.87BMarket Cap-20.19P/E (TTM)
0.000High0.000Low0Volume0.000Open14.740Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)126.81MShares14.76052wk High5.07P/B1.39BFloat Cap14.73052wk Low--Dividend TTM94.60MShs Float14.760Historical High--Div YieldTTM0.00%Amplitude2.010Historical Low--Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
BELLUS Health Stock Forum
BIGGEST MOVERS FROM THIS WEEK
The CEO of $CNS Pharmaceuticals (CNSP.US)$ has disclosed the acquisition of 15,000 shares at a mean price of $0.69 per share. Shares closed the week down 20% at $1.89.
$Dermata Therapeutics (DRMA.US)$ received FDA approval for its proposed protocols and regulations for the Phase 3 clin...
US Economy Stalls as Credit Narrows, Fed's Beige Book Says
The US economy stalled in recent weeks, with hiring and inflation slowing and access to credit narrowing, the Federal Reserve said in its Beige Book survey of regional business contacts.
The Beige Book likely reinforces the chances that Fed policymakers will pause their run of interest-rate hikes following an expected quarter-point increase at the next ga...
– The bank stock was about flat even after the firm reported first-quarter earnings and revenue that topped expectations. Its strong results were driven by higher rates as net interest income jumped 25% year over year. CEO Brian Moynihan said he sees a relatively mild recession in the U.S.
$Bank of New York Mellon (BK.US)$
– The bank’s shares dropped 0.3% after a mixed first-quarter earnings report. While the bank’s earnings ca...
Top Medical News of the Week
Moderna and Merck to develop a cancer vaccine for high-risk melanoma patients
Last week, we had some exciting news on cancer vaccine development announced by Moderna and Merck.
Moderna's vaccine, based on its messenger RNA technology, is being studied in combination with Merck's Keytruda to treat...
No comment yet